Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evan J Begg

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Obstetrics and Gynecology|February 2, 2006
Breastfeeding during tacrolimus therapySharon J Gardiner, Evan J Begg
Clinical Pharmacokinetics|April 11, 2008
Free drug metabolic clearance in elderly peopleJennifer M Butler, Evan J Begg
Pharmacological Reviews|September 14, 2006
Pharmacogenetics, drug-metabolizing enzymes, and clinical practiceSharon J Gardiner, Evan J Begg
Pharmacogenetics and Genomics|May 3, 2005
Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice?Sharon J Gardiner, Evan J Begg
British Journal of Clinical Pharmacology|July 21, 2010
The 'apparent clearance' of free phenytoin in elderly vs. younger adultsDaniel F B Wright, Evan J Begg
Mayo Clinic Proceedings|October 11, 2005
Clopidogrel hypersensitivity syndrome with rash, fever, and neutropeniaMatthew P Doogue, Evan J Begg, Paul Bridgman
British Journal of Clinical Pharmacology|July 9, 2002
Clinical pharmacology: principles and practice of drug therapy in medical educationBrian Whiting, Nicholas H G Holford, Evan J Begg
Pharmacogenomics|December 20, 2011
Pharmacogenetics of drug-metabolizing enzymes: the prodrug hypothesisEvan J Begg, Nuala A Helsby, Berit P Jensen
Pharmacogenomics|June 9, 2012
Institutional profile: The Carney Centre for Pharmacogenomics: a New Zealand focus for personalized medicine researchMartin A Kennedy, Peter R Joyce, Evan J Begg
Adverse Drug Reactions and Toxicological Reviews|July 27, 2002
The effect of dihydropyrimidine dehydrogenase deficiency on outcomes with fluorouracilSharon J Gardiner, Evan J Begg, Bridget A Robinson
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Obstetrics and Gynecology|February 2, 2006
Breastfeeding during tacrolimus therapySharon J Gardiner, Evan J Begg
Clinical Pharmacokinetics|April 11, 2008
Free drug metabolic clearance in elderly peopleJennifer M Butler, Evan J Begg
Pharmacological Reviews|September 14, 2006
Pharmacogenetics, drug-metabolizing enzymes, and clinical practiceSharon J Gardiner, Evan J Begg
Pharmacogenetics and Genomics|May 3, 2005
Pharmacogenetic testing for drug metabolizing enzymes: is it happening in practice?Sharon J Gardiner, Evan J Begg
British Journal of Clinical Pharmacology|July 21, 2010
The 'apparent clearance' of free phenytoin in elderly vs. younger adultsDaniel F B Wright, Evan J Begg
Mayo Clinic Proceedings|October 11, 2005
Clopidogrel hypersensitivity syndrome with rash, fever, and neutropeniaMatthew P Doogue, Evan J Begg, Paul Bridgman
British Journal of Clinical Pharmacology|July 9, 2002
Clinical pharmacology: principles and practice of drug therapy in medical educationBrian Whiting, Nicholas H G Holford, Evan J Begg
Pharmacogenomics|December 20, 2011
Pharmacogenetics of drug-metabolizing enzymes: the prodrug hypothesisEvan J Begg, Nuala A Helsby, Berit P Jensen
Pharmacogenomics|June 9, 2012
Institutional profile: The Carney Centre for Pharmacogenomics: a New Zealand focus for personalized medicine researchMartin A Kennedy, Peter R Joyce, Evan J Begg
Adverse Drug Reactions and Toxicological Reviews|July 27, 2002
The effect of dihydropyrimidine dehydrogenase deficiency on outcomes with fluorouracilSharon J Gardiner, Evan J Begg, Bridget A Robinson
Pageof 6